Food and Beverages
Digestive Enzyme Supplements Market Size to Grow at a CAGR of 7.12% During the Forecast Period 2020–2025
Digestive Enzyme Supplements Market size is valued at $992.3Bn by 2019, and is anticipated to grow at a CAGR of 7.12% during the forecast period 2020-2025. The Digestive Enzyme Supplements Market growth rate is attributed to the rising geriatric population, the rising prevalence of gastrointestinal disorders, increasing awareness about GI health, and focus on preventive health management are expected to be the major driving factor of Digestive Enzyme Supplements industry. Digestive enzymes represent a group of enzymes secreted by the digestive organs, for breaking down complex macromolecules into their constituents, in order to facilitate their absorption by the body. From growing awareness regarding the government initiatives regarding increasing innovation and rise in investment for various public and private organizations related to Digestive Enzyme Supplements is anticipated to propel the Digestive Enzyme Supplements Market during the forecast period 2020-2025.
Key Takeaways
- North America dominated the Digestive Enzyme Supplements Market with a share of 37% in the year 2019.
- The factors such large number of aging population suffering with digestive complications, preference for oily and spicy food coupled with rising preference to sports nutrition products among athletes, fitness enthusiast etc. are amongst the major factor projected to impel growth of Digestive Enzyme Supplements Market.
- High prevalence of GI disorders, the changing lifestyle, unhealthy eating habits, and high disposable income are the key factors owing to the growth in the segment during forecast period 2020-2025.
- Rising Demand For Digestive Enzyme Supplements With Rising Geriatric Population And Prevalence Of Gastrointestinal Disorders:
- Various Side-effects and availability of alternatives:
- In November 2015, Vox Nutrition launched a new private label digestive enzyme supplement, Digestion Enzyme Pro Blend. The product aims to enhance nutrition absorption, assist the body in breaking down difficult proteins, supports healthy digestion, and helps in relieving reactions of common food intolerances.
- In October 2015, XYMOGEN’s production site received approval from Therapeutic Goods Administration (TGA), a pharmaceutical regulatory agency based in Australia, and became the exclusive manufacturer of supplements in the U.S. This strategy was implemented to gain market penetration for digestive enzyme supplements in Australia.






